Combination drug treatment reduces agitation for patients with probable Alzheimer's disease
Tuesday, September 22, 2015 - 13:40
in Health & Medicine
In a preliminary 10-week randomized trial, patients with probable Alzheimer's disease who received the combination medication dextromethorphan-quinidine demonstrated less occurrences and severity of agitation, compared to patients who received placebo, according to a study.